Conversion of stable renal transplant recipients from sandimmune to sang-35, a neoral-equivalent cyclosporine formulation, using a dose-adjusted method
aUniversity of Cincinnati Medical Center (M.R.F., P.W., M.S., V.R.P., T.J.S.), Cincinnati, Ohio, USA;bSangStat Medical Corporation (D.C., T.J.S.), Menlo Park, California, USA